Literature DB >> 15742108

Wilson's disease-cause of mortality in 164 patients during 1992-2003 observation period.

A Członkowska1, B Tarnacka, T Litwin, J Gajda, M Rodo.   

Abstract

We studied the cause of death in a consecutive series of 164 patients with Wilson's disease (WD) diagnosed over an 11 year period. A total of 20 [12% (95% CI 10.3-16.0)] died during the observation period. The relative survival rate of all patients in our group was statistically smaller than in Polish population. The main cause of death was the diagnosis in advanced stage of disease, but in six patients presenting with mild signs, we observed the progression of the disease despite treatment. There was no difference in mortality rate in patients treated with d-penicillamine or zinc sulphate as initial therapy. The prognosis for survival in the majority of WD patients is favourable, provided that therapy is introduced early.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15742108     DOI: 10.1007/s00415-005-0720-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  20 in total

1.  Penicillamine, a new oral therapy for Wilson's disease.

Authors:  J M WALSHE
Journal:  Am J Med       Date:  1956-10       Impact factor: 4.965

2.  Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction.

Authors:  V Yuzbasiyan-Gurkan; A Grider; T Nostrant; R J Cousins; G J Brewer
Journal:  J Lab Clin Med       Date:  1992-09

3.  Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate.

Authors:  A Czlonkowska; J Gajda; M Rodo
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

Review 4.  Wilson's disease: yesterday, today, and tomorrow.

Authors:  J M Walshe
Journal:  Mov Disord       Date:  1988       Impact factor: 10.338

5.  Liver copper concentration in Wilson's disease: effect of treatment with 'anti-copper' agents.

Authors:  K Gibbs; J M Walshe
Journal:  J Gastroenterol Hepatol       Date:  1990 Jul-Aug       Impact factor: 4.029

6.  Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride.

Authors:  J M Walshe
Journal:  Lancet       Date:  1982-03-20       Impact factor: 79.321

7.  The influence of prolonged treatment with D-penicillamine on the immune response in Wilson's disease.

Authors:  A Czlonkowska
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

8.  Initial therapy of patients with Wilson's disease with tetrathiomolybdate.

Authors:  G J Brewer; R D Dick; V Yuzbasiyan-Gurkin; R Tankanow; A B Young; K J Kluin
Journal:  Arch Neurol       Date:  1991-01

9.  The Wilson disease gene: spectrum of mutations and their consequences.

Authors:  G R Thomas; J R Forbes; E A Roberts; J M Walshe; D W Cox
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

10.  Prognosis of Wilsonian chronic active hepatitis.

Authors:  M L Schilsky; I H Scheinberg; I Sternlieb
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

View more
  22 in total

Review 1.  Wilson disease-treatment perspectives.

Authors:  Tomasz Litwin; Karolina Dzieżyc; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

2.  Difficulties in diagnosis and treatment of Wilson disease-a case series of five patients.

Authors:  Anna Członkowska; Karolina Dzieżyc-Jaworska; Bożena Kłysz; Rędzia-Ogrodnik Barbara; Tomasz Litwin
Journal:  Ann Transl Med       Date:  2019-04

Review 3.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

Review 4.  A review and current perspective on Wilson disease.

Authors:  Mallikarjun Patil; Keyur A Sheth; Adarsh C Krishnamurthy; Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2013-07-06

5.  Liver cirrhosis in patients newly diagnosed with neurological phenotype of Wilson's disease.

Authors:  Adam Przybyłkowski; Grażyna Gromadzka; Grzegorz Chabik; Agata Wierzchowska; Tomasz Litwin; Anna Członkowska
Journal:  Funct Neurol       Date:  2014 Jan-Mar

6.  A genetic study of Wilson's disease in the United Kingdom.

Authors:  Alison J Coffey; Miranda Durkie; Stephen Hague; Kirsten McLay; Jennifer Emmerson; Christine Lo; Stefanie Klaffke; Christopher J Joyce; Anil Dhawan; Nedim Hadzic; Giorgina Mieli-Vergani; Richard Kirk; K Elizabeth Allen; David Nicholl; Siew Wong; William Griffiths; Sarah Smithson; Nicola Giffin; Ali Taha; Sally Connolly; Godfrey T Gillett; Stuart Tanner; Jim Bonham; Basil Sharrack; Aarno Palotie; Magnus Rattray; Ann Dalton; Oliver Bandmann
Journal:  Brain       Date:  2013-03-21       Impact factor: 13.501

Review 7.  The Pragmatic Treatment of Wilson's Disease.

Authors:  Annu Aggarwal; Mohit Bhatt
Journal:  Mov Disord Clin Pract       Date:  2014-04-10

Review 8.  Cardiac Involvement in Movement Disorders.

Authors:  Malco Rossi; Nestor Wainsztein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2021-04-07

9.  Comparative assessment of clinical rating scales in Wilson's disease.

Authors:  Hanna M Volpert; Jan Pfeiffenberger; Jan B Gröner; Wolfgang Stremmel; Daniel N Gotthardt; Mark Schäfer; Karl Heinz Weiss; Markus Weiler
Journal:  BMC Neurol       Date:  2017-07-21       Impact factor: 2.474

10.  Designing Clinical Trials in Wilson's Disease.

Authors:  Peter Ott; Aurélia Poujois; Thomas Damgaard Sandahl; Karl Heinz Weiss; Peter Ferenci; Michael L Schilsky; Aftab Ala; Frederick K Askari; Anna Czlonkowska; Ralf-Dieter Hilgers; Eve A Roberts
Journal:  Hepatology       Date:  2021-10-05       Impact factor: 17.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.